Cargando…

Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer

Breast cancer is characterized by a high incidence rate and its treatment challenges, particularly in certain subtypes. Consequently, there is an urgent need for the development of novel therapeutic approaches. Immunotherapy utilizing immune checkpoint inhibitors (ICIs) is currently gaining momentum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hongsheng, Mi, Jintao, Xin, Qi, Cao, Weiwei, Song, Chunjiao, Zhang, Naidan, Yuan, Chengliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582933/ https://www.ncbi.nlm.nih.gov/pubmed/37860188 http://dx.doi.org/10.3389/fonc.2023.1256360

Ejemplares similares

FTO, PIK3CB serve as potential markers to complement CEA and CA15-3 for the diagnosis of breast cancer
por: Mi, Jintao, et al.
Publicado: (2023)

Causality between depression and ankylosing spondylitis in a European population: Results from a Mendelian randomization analysis
por: Zhang, Naidan, et al.
Publicado: (2023)

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
por: Zhang, Wenxiang, et al.
Publicado: (2021)

Exosomes and cancer immunotherapy: A review of recent cancer research
por: Cao, Yue, et al.
Publicado: (2023)

TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress
por: Shen, Xinyuan, et al.
Publicado: (2022)

A Novel Mice Model for Studying the Efficacy and IRAEs of Anti-CTLA4 Targeted Immunotherapy
por: Xu, Shengchao, et al.
Publicado: (2021)

Research progress of nanovaccine in anti-tumor immunotherapy
por: Yao, Min, et al.
Publicado: (2023)

Recent Progress on Therapeutic Vaccines for Breast Cancer
por: Zhang, Lianru, et al.
Publicado: (2022)

Biological Landscape of Triple Negative Breast Cancers Expressing CTLA-4
por: Navarrete-Bernal, María G. C., et al.
Publicado: (2020)

Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments
por: Vitorino, Marina, et al.
Publicado: (2022)

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
por: Luo, Chenyi, et al.
Publicado: (2022)

Confusing signals: Recent progress in CTLA-4 biology
por: Walker, Lucy S.K., et al.
Publicado: (2015)

Recent Progress on Circular RNA Research in Acute Myeloid Leukemia
por: Jamal, Muhammad, et al.
Publicado: (2019)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023)

The progress in our understanding of CIN in breast cancer research
por: Liao, Yu-Yang, et al.
Publicado: (2023)

The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy
por: Xu, Jing, et al.
Publicado: (2023)

Recent Advances in Immunotherapy in Metastatic NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
por: Xing, Liangliang, et al.
Publicado: (2022)

Research progress of abnormal lactate metabolism and lactate modification in immunotherapy of hepatocellular carcinoma
por: Xu, Yiwei, et al.
Publicado: (2023)

Progression in immunotherapy for advanced prostate cancer
por: Liang, Hao, et al.
Publicado: (2023)

The research progress of anti-inflammatory and anti-fibrosis treatment of chronic pancreatitis
por: Li, Bing-Qing, et al.
Publicado: (2022)

Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress
por: Chen, Yushi, et al.
Publicado: (2023)

Clinical Progress of PD-1/L1 Inhibitors in Breast Cancer Immunotherapy
por: Chen, Fei, et al.
Publicado: (2022)

Early treatment of rituximab combined with eltrombopag for secondary thrombocytopenic purpura in rheumatoid arthritis: A case report
por: Zhang, Naidan, et al.
Publicado: (2022)

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic antibody associated vasculitis
por: Zhang, Naidan, et al.
Publicado: (2022)

Development and assessment of a predictive model for early diagnosis of rheumatoid arthritis in southwest China: A new nomogram
por: Zhang, Naidan, et al.
Publicado: (2023)

The recent advances of cancer associated fibroblasts in cancer progression and therapy
por: Wu, Chenxi, et al.
Publicado: (2022)

CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic
por: Callahan, Margaret K., et al.
Publicado: (2015)

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
por: Bie, Fenglong, et al.
Publicado: (2022)

Research progress of Claudin-low breast cancer
por: Pan, Chenglong, et al.
Publicado: (2023)

Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report
por: Varnier, Romain, et al.
Publicado: (2021)

Knowledge structure and hotspots research of glioma immunotherapy: a bibliometric analysis
por: Yuan, Yexin, et al.
Publicado: (2023)

Recent advances progress in radiotherapy for breast cancer after breast-conserving surgery: a review
por: Wang, Yun, et al.
Publicado: (2023)

Research Progress on the Microenvironment and Immunotherapy of Advanced Non-Small Cell Lung Cancer With Liver Metastases
por: Fang, Yujia, et al.
Publicado: (2022)

Adverse Events Following Administration of Anti-CTLA4 Antibody Ipilimumab
por: Karimi, Amirali, et al.
Publicado: (2021)

Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy
por: Xiao, Mingshu, et al.
Publicado: (2022)

Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer
por: Liu, Jianyu, et al.
Publicado: (2021)

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
por: Sobhani, Navid, et al.
Publicado: (2021)

Meta-Analysis of Efficacy From CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
por: Xu, Li, et al.
Publicado: (2022)

Research progress on RNA−binding proteins in breast cancer
por: Chen, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tvg6bg0g2trig07q9epr6t13hm